- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Solid Tumour in Singapore
Total 232 results
-
National University Hospital, SingaporeUnknownAdvanced Solid TumorsSingapore
-
National University Hospital, SingaporeINTRA-IMMUSG PRIVATE LIMITEDUnknown
-
EDDC (Experimental Drug Development Centre), A*STAR...ParexelRecruiting
-
Bristol-Myers SquibbWithdrawnAdvanced Solid TumorsAustralia, Singapore
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
Adagene IncRecruitingAdvanced/Metastatic Solid TumorsSingapore, Australia, United States
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
Kyowa Kirin Co., Ltd.Terminated
-
Otsuka Beijing Research InstituteCompletedMalignant Solid TumourSingapore
-
BayerCompletedAdvanced or Metastatic Solid TumorUnited States, Spain, Korea, Republic of, Belgium, Singapore, Germany
-
National University Hospital, SingaporeAdagene IncActive, not recruitingAdvanced Solid Tumor | HER2-negative Breast CancerSingapore
-
National University Hospital, SingaporeCompleted
-
National Cancer Centre, SingaporeRecruiting
-
National University Hospital, SingaporeNatera, Inc.; The N.1 Institute for Health (N.1)Recruiting
-
National University Hospital, SingaporeUnknownSolid Tumor CancerSingapore
-
Yantai LNC Biotechnology Singapore PTE. LTD.Recruiting
-
National University Hospital, SingaporeRecruiting
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorsSpain, Japan, Taiwan, Italy, Switzerland, Israel, United States, Singapore
-
National Cancer Centre, SingaporeNational Medical Research Council (NMRC), Singapore; ASLAN PharmaceuticalsActive, not recruiting
-
National University Hospital, SingaporeKaryopharm Therapeutics IncCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeCompleted
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | LymphomasSingapore
-
National Cancer Centre, SingaporeCompletedUnspecified Adult Solid Tumor, Protocol SpecificSingapore
-
National University Hospital, SingaporeCompleted
-
National Cancer Centre, SingaporeINTRA-IMMUSG PRIVATE LIMITEDRecruitingHepatocellular Carcinoma | Gastric Cancer | Advanced Solid TumorSingapore
-
SingHealth PolyclinicsCompletedAdvanced Medical Directive, a Legal Document Signed in Advance to State Healthcare PreferencesSingapore
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorSpain, Singapore, Japan, United States, Canada
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Australia, Taiwan, Spain, United Kingdom, France, Korea, Republic of, Canada, Singapore
-
BayerActive, not recruitingAdvanced Solid TumorsUnited States, Singapore, Italy, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid and Hematological TP53wt TumorsFrance, Netherlands, Spain, Germany, Singapore, Japan, Taiwan, United States
-
Singapore General HospitalCompletedSolid Tumor | Histological Type of NeoplasmSingapore
-
BayerRecruitingAdvanced Solid TumorsUnited States, Canada, Singapore, United Kingdom, Belgium
-
National Cancer Centre, SingaporeSingapore Translational Cancer Consortium; Genome Institute of Singapore; Cancer...RecruitingNon-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Advanced Solid TumoursSingapore
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada
-
AmgenCompletedAdvanced Solid TumorsCanada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Debiopharm International SATerminatedSolid TumoursKorea, Republic of, United States, Taiwan, Spain, Singapore
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1)Recruiting
-
Novartis PharmaceuticalsCompletedSolid Tumor With p53 Wild Type StatusFrance, Germany, Singapore, Switzerland, United States
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1); Cancer Science Institute of SingaporeNot yet recruitingBreast Cancer | Solid Tumor | Gastrointestinal CancerSingapore